Roger M. Bjerke
Publications by Year
Research Areas
Radiopharmaceutical Chemistry and Applications, Prostate Cancer Treatment and Research, Peptidase Inhibition and Analysis, Redox biology and oxidative stress, Occupational and environmental lung diseases
Most-Cited Works
- → Detection of colorectal polyps in humans using an intravenously administered fluorescent peptide targeted against c-Met(2015)287 cited
- → Preclinical Efficacy of a PSMA-Targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer(2019)121 cited
- → Mesothelin-Targeted Thorium-227 Conjugate (MSLN-TTC): Preclinical Evaluation of a New Targeted Alpha Therapy for Mesothelin-Positive Cancers(2019)106 cited
- → In Vitro and In Vivo Efficacy of a Novel CD33-Targeted Thorium-227 Conjugate for the Treatment of Acute Myeloid Leukemia(2016)79 cited
- → An efficient chelator for complexation of thorium-227(2016)70 cited
- → Advances in Precision Oncology: Targeted Thorium-227 Conjugates As a New Modality in Targeted Alpha Therapy(2020)55 cited
- → Targeted alpha therapy using a novel CD70 targeted thorium-227 conjugate inin vitroandin vivomodels of renal cell carcinoma(2017)51 cited
- → Synergistic Effect of a Mesothelin-Targeted 227Th Conjugate in Combination with DNA Damage Response Inhibitors in Ovarian Cancer Xenograft Models(2019)51 cited
- → Synergistic Effect of a HER2 Targeted Thorium-227 Conjugate in Combination with Olaparib in a BRCA2 Deficient Xenograft Model(2019)34 cited
- → Identification of the Protein Target of Myelin-Binding Ligands by Immunohistochemistry and Biochemical Analyses(2012)28 cited